Eisai Inactive Page

Eisai Inc., a U.S. pharmaceutical company with headquarters in Nutley, New Jersey, is a fully integrated business with a passionate commitment to patient care. As the pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., Eisai employs 1,819 people and generates an annual revenue of $1 billion. Eisai focuses on discovering and developing innovative therapies to address unmet medical needs within two global business groups: oncology and neurology. Their neurology focus includes dementia-related diseases and neurodegenerative diseases. Eisai's operations span multiple states, with discovery labs located in Massachusetts and Pennsylvania, their global demand chain organization in Maryland and North Carolina, and commercial and clinical development organizations in New Jersey. Eisai Inc. operates as an end-to-end global business within both its oncology and neurology groups, encompassing discovery, development, and marketing capabilities. Their dedication to human health care (hhc) is evident in their mission to increase the benefits of health care for patients and their families. For more information about Eisai Inc., please visit www.eisai.com/US.